Dr. Joshua E. Meyer Named ASTRO Fellow for Leadership in Radiation Oncology

Overview

Dr. Joshua E. Meyer of Fox Chase Cancer Center was honored as a Fellow of the American Society for Radiation Oncology (ASTRO) in 2025, recognizing his significant contributions to radiation oncology research, clinical care, and service. His leadership in gastrointestinal cancer care and translational research exemplifies excellence in advancing cancer treatment.

Background

ASTRO Fellowship is awarded to members who have demonstrated outstanding achievements in radiation oncology through research, clinical practice, and service to the society. Dr. Meyer, a board-certified radiation oncologist, has been with Fox Chase Cancer Center since 2010 and is nationally recognized for his work in gastrointestinal cancers. His career includes multiple awards for education and cancer care excellence, as well as leadership roles in clinical and translational research. This fellowship highlights his impact on both patient care and the broader oncology community.

Data Highlights

Since 2006, fewer than 500 physicians worldwide have been named ASTRO Fellows. Fox Chase Cancer Center has six ASTRO Fellows, a notably high percentage relative to its size. Dr. Meyer has received multiple honors including the Educator of the Year Award (2015, 2022), the Paul Engstrom Award for Cancer Care Excellence (2025), and research grants from Varian Medical Systems and the In Vino Vita Pilot Project.

Key Findings

• Dr. Meyer was named an ASTRO Fellow in 2025 for his significant contributions to radiation oncology.
• He serves as Vice Chair of Translational Research and Professor in Radiation Oncology at Fox Chase Cancer Center.
• He directs clinical and translational research for the Gastrointestinal Service Line and the Pancreatic Cancer Institute at Fox Chase.
• His research includes adaptive radiation therapy in rectal cancer, supported by industry grants.
• He has been repeatedly recognized for excellence in education and cancer care.
• Dr. Meyer actively contributes to professional societies shaping radiation oncology practice and policy.

Clinical Implications

Recognition as an ASTRO Fellow underscores Dr. Meyer's role in advancing radiation oncology through innovative research and clinical leadership, which translates into improved patient access to cutting-edge treatments and clinical trials. His mentorship and guideline development efforts help ensure that emerging oncologists are well-equipped to deliver high-quality care. This honor reflects a commitment to enhancing outcomes for patients with gastrointestinal and other cancers.

Conclusion

Dr. Joshua E. Meyer's ASTRO Fellowship highlights his exemplary contributions to radiation oncology, reinforcing Fox Chase Cancer Center's reputation as a leader in cancer care and research. His ongoing work promises to continue shaping the future of cancer treatment and education.

Related Resources & Content

1. Fox Chase Cancer Center 2025 -- Dr. Joshua E. Meyer Named ASTRO Fellow